baseline_drift
TL2 Analytical chemist · Wrocław, PL
Instrument tech turned analyst. If your baseline looks like that, check the lamp before you blame the sample.
Joined 1 November 2024 · last posted 2d · groups: analytical-chemists
78Posts here
0Topics
0Solutions
344Likes received
176Likes given
20Badges
144Days visited
1.5kPosts read
Most-liked posts
-
[2026 update] What a good consultation looks like from the other side Replied, post #13 · Clinical › Prescriber conversations · 25 Jan 2026 · 31 likes Asking about monitoring: understand what lab work will be done, how often, and what you will be monitored for. A plan is better than ad-hoc monitoring.
-
Validating a method you did not develop — does this still hold? Replied, post #134 · Analytics › Method validation · 19 Mar 2025 · 31 likes Picking up post #131: that is the part I would want checked first. Accuracy: the method measures what you intend to measure. For purity methods, this is tested by…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #55 · Evidence › Journal club · 28 Aug 2025 · 29 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #10 · Clinical › Bloodwork · 6 Jan 2025 · 28 likes Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age, and weight. A small change in creatinine might not mean a real change in kidney…
-
Second pass at: When your prescriber and the evidence disagree Replied, post #48 · Clinical › Prescriber conversations · 10 Jul 2026 · 27 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #65 · Practice › Dosing & titration · 18 Feb 2026 · 27 likes On post #61 — agreed on the reasoning, with one qualification. Dose equivalence between different incretin analogues is a weak concept. The molecules differ in…
Where this member posts
Badges earned, in order
| Badge | Tier | Granted |
|---|---|---|
| First Reply | bronze | 3 Nov 2024 |
| Basic User | bronze | 5 Nov 2024 |
| Read the Guidelines | bronze | 7 Nov 2024 |
| Welcome | bronze | 13 Nov 2024 |
| First Link | bronze | 13 Nov 2024 |
| Member | bronze | 20 Nov 2024 |
| First Tag | bronze | 28 Nov 2024 |
| Sourced | bronze | 29 Nov 2024 |
| First Quote | bronze | 4 Dec 2024 |
| Asked Well | bronze | 8 Dec 2024 |
| Reader | bronze | 12 Dec 2024 |
| Editor | bronze | 27 Jan 2025 |
| First Chromatogram | bronze | 11 Mar 2025 |
| Nice Post | bronze | 12 Apr 2025 |
| Good Post | silver | 13 Apr 2025 |
| Method First | silver | 7 May 2025 |
| Reads a COA | silver | 17 Jun 2025 |
| Thank You | silver | 5 Jul 2025 |
| Wiki Maintainer | gold | 4 Oct 2025 |
| Anniversary | silver | 1 Nov 2025 |